The Best 15 Minutes You’ll Spend on Clinical Trials Today

How Unlearn Boosts Trial Power Using the FDA’s AI Framework

How we’re helping biotechs like ProJenX run smarter ALS trials

Unlocking Smarter Parkinson’s Disease Trials with Digital Twins

Smarter Endpoints, Stronger Trials: How AI-Optimized Measures Are Advancing Neurodegenerative Disease Research

Why the FDA’s New AI Guidelines Matter for Clinical Research

Why Unlearn and APST’s Partnership Matters for ALS Innovation

New Model Release for ALS: Accelerating Clinical Trials with Advanced Forecasting

Unlearn Introduces Digital Twin Generators for Psychiatric Disorders

Modeling Alzheimer's Disease Progression: What’s New in Our Latest DTG Update

The Art of Artificial Intelligence Research

Unlearn is SOC2 Type II Certified